Ondero Met 2.5mg/1000mg Tablet
Metformin (1000mg) + Linagliptin (2.5mg)
Primary uses of : Type 2 diabetes
-
-
-
*
-
|
Composition
|
Metformin (1000mg) + Linagliptin (2.5mg) |
|
Potentially Unsafe With
|
Alcohol |
|
Side Effect
|
Common
Diarrhoea, Nausea, Vomiting, Stomach upset, Headache, Nasal congestion, Sore throat, Respiratory tract infection, Hypoglycaemia (low blood sugar level) in combination with insulin or sulphonylurea. |
|
How to works
|
How Ondero Met Tablet works
Ondero Met 2.5mg/1000mg Tablet is a combination of two antidiabetic medicines: Metformin and Linagliptin. Metformin is an anti-diabetic medication (biguanide). It works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin. Linagliptin is a DPP-4 inhibitor which works by increasing the release of insulin from the pancreas and decreasing the hormones that raise blood sugar levels. This reduces both fasting and postmeal sugar levels. Together, they provide better control of blood sugar. |
